MedTrace Logo

Expand Management of Blood Pressure With Renal Denervation in Patients Undergoing Staged PCI for Advanced Coronary Artery diseasE

NCT07602790 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2026-05-22

No results posted yet for this study

Summary

EMBRACE is a randomized, controlled, multicenter clinical study evaluating the effect of renal denervation on clinical adverse events in hypertensive patients undergoing staged percutaneous coronary intervention (PCI) for multivessel coronary artery disease.

Conditions

  • Multivessel Coronary Artery Disease
  • Hypertension Resistant to Conventional Therapy

Interventions

DEVICE

Renal denervation

Catheter-based renal denervation performed during a standard renal artery catheterization procedure using a dedicated renal denervation system, according to the study protocol. The procedure is performed in addition to ongoing antihypertensive medical therapy, which is continued throughout the study as clinically indicated.

Sponsors & Collaborators

  • Ceric Sàrl

    lead INDUSTRY

Principal Investigators

  • Felix Mahfoud, Prof. · Departement Biomedizin DBM Hebelstrasse

  • Roxana Mehran, Prof. · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-11-30
Primary Completion
2030-11-30
Completion
2033-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07602790 on ClinicalTrials.gov